MacroCure

Biotechnology, Health Care, Pharmaceutical
Founded in 2008-01-01
Petah Tiqva, HaMerkaz, Israel
http://www.macrocure.com
For Profit

About MacroCure

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young adults healthy donor blood. The activated cells provide the natural environment for wound healing, and ensure that necessary cell activities and factor secretions are maintained as required for wound healing. This novel concept is the first of its kind in the field of wound therapy.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 9 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 48000000 USD
  • Last Funding: 35000000 USD (Series A)
  • Funding Status: M&A

Technology Stack

MacroCure actively uses 9 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Petah Tiqva, HaMerkaz, Israel